David Hardick
12Patents
1h-index
39Co-inventors
54Inventor score
Filing activity: Apr 16, 1999 → Jul 29, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11725010B2 | Polyheterocyclic compounds as METTL3 inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10538530B2 | Vasopressin receptor antagonists and products and methods related thereto | Chemistry; Metallurgy | 1 | Active |
| US9024033B2 | Anti-malarial agents | Emerging Cross-Sectional Technologies | 1 | Active |
| US11186577B2 | Vasopressin receptor antagonists and products and methods related thereto | Chemistry; Metallurgy | 1 | Active |
| US12358915B2 | METTL3 inhibitory compounds | Chemistry; Metallurgy | 0 | Active |
| US12195458B2 | Polyheterocyclic compounds as METTL3 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11858943B2 | Vasopressin receptor antagonists and products and methods related thereto | Chemistry; Metallurgy | 0 | Active |
| US6518316B1 | Cytokine production and tyrosine kinase inhibitors | Chemistry; Metallurgy | 0 | Expired |
| US9527853B2 | Fused triazole derivatives as gamma secretase modulators | Chemistry; Metallurgy | 0 | Active |
| US11541132B2 | Radiolabeled compounds | Chemistry; Metallurgy | 0 | Active |
| US12152038B2 | Vasopressin receptor antagonists and products and methods related thereto | Chemistry; Metallurgy | 0 | Active |
| US6197811A | Cytokine production inhibitors | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.